About EpiBiologics
EpiBiologics is a private company based in San Mateo, California, incorporated in 2021 in Delaware. It has reported $73,050,000 raised in one offering on Form D since April 2023. Its chief executive is Ann Lee-Karlon.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 21, 2022 | Apr 28, 2023amended Apr 25, 2024 | $73,050,000fully sold | 15 | $4.8M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on EpiBiologics's Form D filed Apr 25, 2024.
JC
Jason Coloma
Director
AK
Ann Lee-Karlon
CEO and director
SB
Samuel Bjork
Director
Alexandra Cantley
Director
Also a director at Auron Therapeutics, Cirrus Therapeutics and Crossbow Therapeutics.
MM
Mitchell Mutz
Executive officer and director
SM
Seiji Miyahara
Director
JW
James Wells
Director